Wendy Stock to Drugs, Investigational
This is a "connection" page, showing publications Wendy Stock has written about Drugs, Investigational.
Connection Strength
0.890
-
Counterpoint: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML. Oncology (Williston Park). 2017 Mar 15; 31(3):190, 192.
Score: 0.562
-
Clinical trials in adult AML. Clin Adv Hematol Oncol. 2009 Jun; 7(6):8-10.
Score: 0.328